Table 2 presents the quantitative analysis of HHV-6A/B IgM and IgG, along with EBV/EBNA-1, EBV/VCA,and CMV IgG antibody titers, highlighting significant differences between MS patients and HCs. The gene discussed is CD40LG; the disease is myeloid sarcoma.